Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0HZ2A
|
||||
| Former ID |
DIB008833
|
||||
| Drug Name |
Recombinant factor VIIa PEGylated liposomal
|
||||
| Synonyms |
Recombinant factor VIIa; Recombinant factor VIIa (PEGylated liposomal (NecLip), Hemophilia A) Recoly
|
||||
| Indication | Factor VII deficiency [ICD10:D68] | Phase 1/2 | [530934] | ||
| Company |
Recoly NV
|
||||
| Target and Pathway | |||||
| Target(s) | Coagulation factor VII | Target Info | Modulator | [543607] | |
| KEGG Pathway | Complement and coagulation cascades | ||||
| PANTHER Pathway | Angiogenesis | ||||
| Blood coagulation | |||||
| PathWhiz Pathway | Coagulation | ||||
| Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
| Extrinsic Pathway of Fibrin Clot Formation | |||||
| Gamma-carboxylation of protein precursors | |||||
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.